Search

everythinglearnresearchcommunity

for

Search:↓

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

A new model can predict drug-disease links well, helping drug research.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Genomics can improve patient care by using DNA to create personalized treatment plans.

Forensic DNA phenotyping can help generate new leads in cold cases but faces accuracy, legal, and acceptance challenges.

Engineered protein hydrogels improve medical treatments by mimicking natural body structures.

Portable point-of-care testing can improve quick and accurate genetic disorder detection.

Computational methods help design drugs targeting prostate cancer proteins.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

New DNA analysis and machine learning are advancing forensic science, improving accuracy and expanding into non-human applications.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Cell-based screening methods are useful and cost-effective for drug discovery but have pros and cons.

Machine learning helps find new uses for existing drugs, improving healthcare.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.